[Federal Register Volume 85, Number 3 (Monday, January 6, 2020)]
[Notices]
[Page 506]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-28449]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Healthcare Infection Control
Practices Advisory Committee (HICPAC). This meeting is open to the
public, limited only by the space available. The meeting room
accommodates up to 120 people. The public is also welcome to listen to
the meeting via teleconference at 1-800-857-2850, passcode: 2622054;
100 teleconference lines are available.
DATES: The meeting will be held on March 5, 2020, 9:00 a.m. to 5:00
p.m., EST, and March 6, 2020, 9:00 a.m. to 12:00 p.m., EST.
ADDRESSES: Centers for Disease Control and Prevention, Global
Communications Center, Building 19, Auditorium B, 1600 Clifton Road NE,
Atlanta, Georgia 30329-4027 and teleconference at 1-800-857-2850,
passcode: 2622054.
FOR FURTHER INFORMATION CONTACT: Koo-Whang Chung, M.P.H., HICPAC,
Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton
Road NE, Mailstop H16-3, Atlanta, Georgia 30329-4027; Telephone: (404)
498-0730; Email: [email protected].
SUPPLEMENTARY INFORMATION: Time will be available for public comment.
The public is welcome to submit written comments in advance of the
meeting. Comments should be submitted in writing by email to the
contact person listed below. The deadline for receipt of written public
comment is February 20, 2020. All requests must contain the name,
address, and organizational affiliation of the speaker, as well as the
topic being addressed. Written comments should not exceed one single-
spaced typed page in length and delivered in 3 minutes or less. Members
of the public who wish to provide public comments should plan to attend
the public comment session at the start time listed. Please note that
the public comment period may end before the time indicated, following
the last call for comments. Written comments received in advance of the
meeting will be included in the official record of the meeting.
Registration is required to attend in person or on the phone.
Interested parties must be processed in accordance with established
federal policies and procedures and may register at https://www.cdc.gov/hicpac.
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion
(DHQP), the Director, National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), the Director, CDC, and the Secretary,
Health and Human Services, regarding (1) the practice of healthcare
infection prevention and control; (2) strategies for surveillance,
prevention, and control of infections, antimicrobial resistance, and
related events in settings where healthcare is provided; and (3)
periodic updating of CDC guidelines and other policy statements
regarding prevention of healthcare-associated infections and
healthcare-related conditions.
Matters To Be Considered: The agenda will include updates on CDC's
activities for prevention of healthcare-associated infections. It will
also include updates from the following HICPAC workgroups: The
Healthcare Personnel Guideline Workgroup; the Neonatal Intensive Care
Unit (NICU) Guideline Workgroup; the National Healthcare Safety Network
(NHSN) Workgroup; and the Bloodstream Infection Workgroup. The agenda
also includes updates on CDC and DHQP activities. Agenda items are
subject to change as priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-28449 Filed 1-3-20; 8:45 am]
BILLING CODE 4163-18-P